Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117919662 | 11791966 | 2 | F | 201312 | 20160722 | 20151201 | 20160729 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-66840BI | BOEHRINGER INGELHEIM | 61.46 | YR | M | Y | 0.00000 | 20160729 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117919662 | 11791966 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | U | 22512 | 150 | MG | CAPSULE | |||||||
| 117919662 | 11791966 | 2 | C | RAPAFLO | SILODOSIN | 1 | Oral | 0 | 8 | MG | CAPSULE | ||||||||
| 117919662 | 11791966 | 3 | C | MULTAQ | DRONEDARONE | 1 | Oral | 0 | 400 | MG | TABLET | ||||||||
| 117919662 | 11791966 | 4 | C | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | EXTENDED RELEASE TABLET 24 HOUR; 1/2 TABLET DAILY | 0 | 50 | MG | ||||||||
| 117919662 | 11791966 | 5 | C | EXFORGE | AMLODIPINE BESYLATEVALSARTAN | 1 | Oral | STRENGTH: 5-320 MG; 1/2 TABLET DAILY | 0 | TABLET | |||||||||
| 117919662 | 11791966 | 6 | C | CAPSAICIN. | CAPSAICIN | 1 | Oral | STRENGTH: 0.025%; APPLY GENTLY TO AFFECTED AREA 3 TO 4 TIMES DAILY | 0 | CREAM | |||||||||
| 117919662 | 11791966 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG | 0 | 20 | MG | TABLET | QD | ||||||
| 117919662 | 11791966 | 8 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | FORMULATION: INHALATION AEROSOL SOLUTION; 2 PUFFS EVERY 4-6 HOURS | 0 | ||||||||||
| 117919662 | 11791966 | 9 | C | DOXYCYCLINE HYCLATE. | DOXYCYCLINE HYCLATE | 1 | Oral | 200 MG | 0 | 100 | MG | CAPSULE | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117919662 | 11791966 | 1 | Atrial fibrillation |
| 117919662 | 11791966 | 2 | Product used for unknown indication |
| 117919662 | 11791966 | 3 | Product used for unknown indication |
| 117919662 | 11791966 | 4 | Product used for unknown indication |
| 117919662 | 11791966 | 5 | Product used for unknown indication |
| 117919662 | 11791966 | 6 | Product used for unknown indication |
| 117919662 | 11791966 | 7 | Product used for unknown indication |
| 117919662 | 11791966 | 8 | Wheezing |
| 117919662 | 11791966 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117919662 | 11791966 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117919662 | 11791966 | Internal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |